In conclusion, this retrospective multicenter study demonstrates that pregnancy outcome in women with type 2 and gestational diabetes mellitus treated with insulin lispro protamine suspension was similar to those of those treated with NPH insulin, except for a lower insulin requirement. This evidence concerns the gene INS and gestational diabetes.